FDA Clears AI Tool for Diabetic Retinopathy Screening

Lead: The FDA granted clearance to an AI diagnostic tool that autonomously screens retinal images for diabetic retinopathy, enabling deployment in primary care and community clinics.

Impact

Clearance may broaden access to early detection in underserved areas, but requires post-market monitoring and clinician oversight policies.

Verification Log

• source: FDA press release

url: "https://www.fda.gov/example"
timestamp: "2026-06-02T11:00:00Z"
excerpt: "FDA clears AI tool for autonomous screening of diabetic retinopathy."
check_result: corroborated

Footer

Source Original: FDA
Link Canonical: https://www.fda.gov/example
Date of Collection: 2026-06-02